Evidence map›Paper›PMID 37145199›Full record

ArticleJournal of cancer research and clinical oncology2023

Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project.

Friederike Braulke, Servet Para, Bernd Alt-Epping, Mitra Tewes, Markus Bäumer, Birgit Haberland, Regine Mayer-Steinacker, Anne Hopprich, Maike de Wit, Michaela Grabe and 25 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Effectiveness of ePRO-based symptom management for cancer patients: a systematic review and meta-analysis of randomized controlled studies.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 2 countries.

Friederike BraulkeComprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
Servet ParaInterdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.
Bernd Alt-EppingDepartment of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Mitra TewesDepartment of Palliative Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Markus BäumerKliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany.
Birgit HaberlandLMU Klinikum München, München, Germany.
Regine Mayer-SteinackerComprehensive Cancer Center Ulm. Medical Center, Ulm University, Ulm, Germany.
Anne HopprichDepartment of Radiooncology and Radiotherapy, University Medical Center Mainz, Mainz, Germany.
Maike de WitCancer Center Berlin-Neukölln - Vivantes Klinikum Neukölln, Berlin, Germany.
Michaela GrabeCancer Center Rems-Murr-Hospital Winnenden, Winnenden, Germany.
Sophia Bender-SäbelkampfUniversitätsklinikum Erlangen, Erlangen, Germany.
Caroline WeßlingClemenshospital Münster, Münster, Germany.
Christoph AulmannAugsburg University Hospital, Augsburg, Germany.
Christina GerlachDepartment of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Pascale RegincosClinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
Ferdinand FischerHospital Ludwigshafen am Rhein gGmbH, Ludwigshafen, Germany.
Soraya HaarmannKliniken Heilbronn GmbH, Fachklinik Löwenstein, Löwenstein, Germany.
Tatjana HuysUniversitätsklinikum Gießen, Giessen, Germany.
Sabine DrygasBrüderkrankenhaus St. Josef Paderborn, Paderborn, Germany.
Anett RambauCaritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.
Alexander KianiKlinikum Bayreuth GmbH, and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Astrid SchnabelLeipzig University Cancer Center, Leipzig, Germany.
Christoph BuhlDepartment of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.
Stefanie SeipkeComprehensive Cancer Center, Hannover Medical School, Hannover, Germany.
Sonja HiemerKlinikum St. Georg Leipzig, Leipzig, Germany.
Silke PolataEvangelisches Waldkrankenhaus Berlin-Spandau, Berlin, Germany.
Maximilian MeßmannDepartment of Palliative Medicine, Hospital St. Elisabeth Straubing GmbH, Straubing, Germany.
Anna HansmeierMathias-Spital Rheine-Ibbenbüren, Rheine, Germany.
Louiza AnastasiadouAgaplesion Markus Krankenhaus Frankfurt, Frankfurt, Germany.
Anne LetschDepartment of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Daniel WechtSpecialist Care in Oncology and Palliative Care, University Hospital Gießen and Marburg, Marburg, Germany.
Matthias Hellberg-NaegeleAdvanced Practice Nurse, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Utz KrugDepartment of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.
Ulrich Wedding *Department of Palliative Care, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany. ulrich.wedding@med.uni-jena.de.ORCID http://orcid.org/0000-0002-0333-8643
Birgitt van Oorschot *Interdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.
Heidelberg University · DEKlinikum Leverkusen · DEUniversitätsklinikum Gießen und Marburg · DEUniversitätsklinikum Würzburg · DEAgaplesion Markus Hospital · DEBarmherzige Brüder Klinikum St. Elisabeth in Straubing · DEBayreuth Medical Center · DEBrüderkrankenhaus St. Josef Paderborn · DECaritas-Krankenhaus Bad Mergentheim · DEClemenshospital Münster · DEJena University Hospital · DEJohannes Gutenberg University Mainz · DEKliniken Maria Hilf · DEKlinikum Ludwigshafen · DEKlinikum Rheine · DEKlinikum St. Georg · DEKlinikum Stuttgart · DELMU Klinikum · DEMedizinische Hochschule Hannover · DERems-Murr-Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGuidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain knowledge on SC procedures in Oncology Centers (OCs) for advanced cancer patients and a first impression on the consequences of SC.

methodsThe KeSBa project consisted of three phases: pilot, 3 months screening and feedback phase. Participating OCs decided to use either the Minimal Documentation System (MIDOS) or the Integrated Palliative care Outcome Scale (IPOS) and defined the cutoff values for positive screening results.

resultsOut of 172 certified German OCs, 40 (23%) participated in the KeSBa pilot phase, 29 (16.8%) in the 3 months screening phase using MIDOS (n = 18, 58.6%) or IPOS (n = 11, 41.3%) and in the feedback round. 25/29 performed paper-based screening (86.2%). 2.963 CPs were screened. Results were documented for 1255 (42.2%, SC +) positive and 874 (29.5%, SC-) negative screenings depending on the center´s schedules: 452 SC + CPs (28.4%) and 42 SC- CPs (2.6%) had contact to specialized palliative care or other supportive specialist teams afterwards, 458 SC + CPs (28.8%) and 605 SC- CPs (38.1%) remained in standard oncology care. In the feedback round missing resources (personal and IT) and improved communication were mentioned most often.

conclusionRoutine SC is feasible in advanced CPs treated in OCs but associated with considerable workload. In 42.2% of CPs SC was classified as positive, indicating the need of further diagnostics or professional judgment. SC requires staff and IT resources.

Indexed as

Early Detection of CancerNeoplasmsHumansMedical OncologyPalliative CareProspective StudiesCancerIPOSMIDOSPalliativeScreeningSupportive

Identifiers

PMID37145199
PMCPMC10374724
OpenAlexW4372291499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.